Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Cardiotoxicity × Cardiac Rehabilitation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Cardiotoxicity 1 Breast Neoplasms 1

Interventions

Echocardiography 14 Doxorubicin 10 Exercise 9 Electrocardiography 7 Trastuzumab 6 Cyclophosphamide 5 Carvedilol 5 Docetaxel 3 Atorvastatin 3 salicylhydroxamic acid 2 sacubitril and valsartan sodium hydrate drug combination 2 empagliflozin 2 dapagliflozin 2 Tablets 2 Social Determinants of Health 2 Silymarin 2 Magnetic Resonance Spectroscopy 2 Ivabradine 2 High-Intensity Interval Training 2 Exercise Test 2 Chemoradiotherapy 2 Blood Specimen Collection 2 Bisoprolol 2 Antineoplastic Agents 2 Anthracyclines 2 sulforaphane 1 schizandrin 1 pegfilgrastim 1 nicotinamide-beta-riboside 1 mitoquinone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03964142 2023-05-12

ONCORE

Hospital Clinico Universitario de Santiago

Phase NA Completed

Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡